Clinical Trials Directory

Trials / Completed

CompletedNCT05279469

D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients

D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in SARS-COV-2 Patients: A Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
465 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.

Detailed description

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients. It has been reported that COVID 19 is associated with hemostatic abnormalities and elevated D-Dimer level, so its level is used to predict severity of disease.

Conditions

Interventions

TypeNameDescription
OTHERno intervention, just observational for D-Dimer level in bloodobservation for basal D-Dimer and 48 hours later D-Dimer in blood for ICU SARS.COV.2 patients

Timeline

Start date
2021-06-10
Primary completion
2022-03-03
Completion
2022-03-09
First posted
2022-03-15
Last updated
2022-03-15

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05279469. Inclusion in this directory is not an endorsement.